Skip to main content
OpenTrials
Completed

NCT Number: NCT01843153

Continuous Versus Intermittent Sciatic Block for Total Knee Arthroplasty

The role of a sciatic block in addition to a femoral block remains controversial. The study addresses this topic by comparing a continuous block versus an injection on demand.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Total Knee Arthroplasty Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

KKH Dormagen

Dormagen, D-51375, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients scheduled for total knee arthroplasty

Exclusion criteria

  • failure to establish femoral and sciatic block
  • insufficient analgesic effect of the block
  • patient declines to participate

Treatment and study plan

Ropivacaine

Drug

Primary outcomes

  1. pain score (VRS)

    Time frame: 4 days

Secondary outcomes

  1. frequency of injections into the sciatic catheter

    Time frame: 4 days

Sponsors and collaborators

Lead sponsor

Kreiskrankenhaus Dormagen

Other

Registry information

Official study title

Continuous Versus Intermittent Sciatic Block Combined With a Continuous Femoral Block for Patients Undergoing Total Knee Arthroplasty: a Prospective, Randomized Trial.

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Apr 30, 2013
Registry last updated
Mar 31, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.